Kiran Mazumdar-Shaw has named her niece Claire Mazumdar as her successor at Biocon, but clarified she won't be retiring anytime soon. Mazumdar-Shaw has a 5-year succession plan in place for her biotechnology group.
Claire Mazumdar, the founding CEO of Bicara Therapeutics, will succeed Mazumdar-Shaw in a phased manner. Mazumdar-Shaw believes Claire has the skills to run a company and has seen her niece prove herself in her current role.
Claire Mazumdar is a biotech specialist with a PhD from Stanford University School of Medicine and an MBA from Stanford University Graduate School of Business. She took over as CEO of Bicara in 2018 and has experience working with venture capital firms and medicine development companies.
